Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Tokyo Big Sight

Nov 10, 2019 9:30 AM - Nov 12, 2019 5:40 PM

3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan

16th DIA Japan Annual Meeting 2019

Delivering Rational Medicine for All People in the Globe

[S43] Virtual Clinical Trials: Roadmap for Implementation in Japan

Session Chair(s)

Takayuki  Imaeda, MPharm, MS

Takayuki Imaeda, MPharm, MS

Head of Regulatory Sciences

Pfizer R&D Japan, Japan

Virtual clinical trial (VCT) is one of the hot topics in drug development as a way to enhance patients’ access to clinical trials. In contrast to several used cases available globally, only a few examples exist in Japan. In this session, we will discuss the benefits and obstacles to implement VCT in Japan from the study site and sponsor’s perspective after the global sponsor’s presentation. We will also introduce new technologies and approaches for VCT including eConsent, direct-to & from-patient, remote medicine, wearable device, ePRO, and smartphone apps and the challenges associated with them. Lastly, we will discuss the roadmap towards successful implementation, including what needs to evolve and potential disease areas, with key stakeholders from patients, study sites and pharmaceutical companies.


Soyoku  Nobeyama, MSc

Direct-to-Patient Clinical Trial Model -Promises and Challenges-

Soyoku Nobeyama, MSc

Janssen Clinical Innovation, United States

Clinical Innovation Leader

Atsushi  Kitamura, MS

Implementation of “Home Visits” in Clinical Trials in Japan: Impact on Patients and Challenges

Atsushi Kitamura, MS

Pfizer R&D Japan G.K., Japan

Director, Clinical Development Quality

Haruo  Kuroki, MD, PhD

Virtual Clinical Trials: Roadmap for Implementation in Japan

Haruo Kuroki, MD, PhD

Sotobo Child Clinic, Japan


Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.